Zimmer Biomet

What Zimmer Biomet does

Zimmer Biomet Holdings, Inc. is a global medical technology company founded in 1927 in Warsaw, Indiana, that designs, manufactures, and sells orthopedic and musculoskeletal products to hospitals, ambulatory surgery centers, and orthopedic surgeons across more than 40 countries. Its product portfolio spans knee implants (the Persona family, Oxford Cementless Partial Knee, Persona Revision Knee, Persona OsseoTi Keel Tibia), hip implants (Z1 Triple-Taper, iTaperloc Complete, iG7 Hip System), shoulder, elbow, foot and ankle (Paragon 28 Phantom curved TTC nail), trauma, craniomaxillofacial, biologics, bone cement, infection solutions, and sports medicine soft-tissue repair products (via the Embody acquisition).

The company is repositioning from a pure implant manufacturer into an integrated musculoskeletal platform through the ZBEdge Dynamic Intelligence suite, which connects the ROSA Knee robotic system, the exclusively distributed THINK Surgical TMINI miniature robot, the mBôs semi-autonomous robotic system (acquired from Monogram Technologies), the Persona IQ smart knee implant (with Canary Medical canturio te sensors generating kinematic data), the mymobility patient app, the WalkAI recovery tracking platform, the OptiVu mixed-reality navigation system, the HAMMR automated hip impactor, and ZBEdge Analytics. Pricing on implants is negotiated through hospital GPO contracts and is not publicly disclosed, while robotics systems and digital health platforms use per-procedure or subscription models, creating a hardware-plus-recurring mix.

Zimmer Biomet generates revenue primarily through direct field sales, supported by approximately 2,500 U.S. sales representatives currently being converted from 1099 independent contractor status to dedicated FTE positions (target completion end of 2027), with parallel direct and distributor coverage in EMEA, Asia Pacific, and Latin America. FY2025 revenue reached $8.23 billion (+7% year-over-year), with Q1 2026 net sales of $2.087 billion (+9.3% year-over-year). The company has executed five acquisitions since 2023 (Embody, OSSIS, OrthoGrid, Paragon 28, and Monogram Technologies) to build out AI surgical guidance, foot and ankle, sports medicine, 3D-printed patient-matched implants, and autonomous robotics, while pursuing ISO 27001 certification and FDA Breakthrough Device Designations to support global commercialization.

Name

Zimmer Biomet

Legal name

Zimmer Biomet Holdings, Inc.

Website

https://zimmerbiomet.com

Company type

Public

Founded year

1927

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Zimmer Biomet is a global medical technology company specializing in musculoskeletal healthcare, manufacturing orthopedic implants, surgical robotics, and digital health platforms. It serves hospitals, ambulatory surgery centers, and orthopedic surgeons across more than 40 countries with knee, hip, foot and ankle, trauma, and sports medicine products.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Healthcare & Assistive Robotics (HDAAAIAC)

Keywords

• Orthopedic medical devices
• Musculoskeletal healthcare
• Joint replacement implants
• Surgical robotics systems
• Digital health platforms

Headquarters

HQ city

Warsaw

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Orthopedic Implants and Devices: Primary revenue stream from selling orthopedic implants including knee, hip, shoulder, foot & ankle, and other musculoskeletal devices to hospitals and healthcare providers worldwide.
2. Surgical Robotics and Digital Health: Revenue from robotic surgical systems including ROSA Knee, TMINI (distributed), and related software and services. Digital health platforms including mymobility app and ZBEdge suite.
3. Patient Monitoring Services: Persona IQ smart knee implant with integrated sensors enabling remote patient monitoring and data collection.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Zimmer Biomet designs, manufactures, and sells orthopedic reconstructive implants and surgical technologies for joint replacement, sports medicine, trauma, and spine. Its portfolio spans knee, hip, shoulder, foot & ankle, and trauma devices, supplemented by the ROSA Knee robotic platform, mBôs semi-autonomous robotic system, TMINI miniature robot, Persona IQ smart implants, OrthoGrid Hip AI, WalkAI recovery tracking, and the mymobility digital care platform. The ZBEdge Dynamic Intelligence suite integrates these robotics, AI, and digital health offerings across the patient care journey.

Product overview

Zimmer Biomet is a global medical technology company specializing in musculoskeletal healthcare with a comprehensive orthopedic product portfolio. The company operates a platform-plus-modules architecture centered on the ZBEdge Dynamic Intelligence platform, which integrates robotics (ROSA Knee), smart implants (Persona IQ with Canary Medical sensors), digital health (mymobility app, WalkAI recovery tracking), and mixed reality (OptiVu). The core product lines span knee implants (Persona family, Oxford Cementless Partial Knee, Persona Revision), hip implants (Z1 Triple-Taper, iTaperloc, iG7), robotic systems (ROSA Knee, TMINI via THINK Surgical partnership, mBôs autonomous robot from Monogram acquisition), and foot/ankle solutions (Paragon 28 Phantom curved TTC nail). Recent acquisitions have expanded capabilities in AI surgical guidance (OrthoGrid Hip AI), sports medicine (Embody collagen implants), and personalized 3D-printed implants (OSSIS).

Differentiator

Problem solved

Functional benefit

Brands

• ZBX: ZBX ASC Solutions - specialized solutions for ambulatory surgery centers
• ZBEdge
• ROSA
• mBôs
• Persona IQ
• mymobility
• OptiVu
• WalkAI

Products and services

• ROSA Knee System Robotic-assisted surgical system for knee replacement procedures providing precision guidance during surgery, part of the ZBEdge robotics portfolio for orthopedic surgeons and hospitals.
• Persona IQ Smart Knee Implant Smart knee implant with embedded sensors that generates kinematic data (step count, range of motion) for post-operative recovery monitoring, using Canary Medical technology integrated into the Persona knee platform.
• Oxford Cementless Partial Knee Partial knee replacement system with cementless fixation technology for unicompartmental knee arthroplasty.
• HAMMR Automated Hip Surgical Impactor System Automated hip surgical impactor system designed to improve consistency and efficiency during hip replacement procedures.
• ZBEdge Dynamic Intelligence Platform Integrated digital health platform connecting robotics, smart implants, mixed reality, and data analytics to provide comprehensive patient care data across the orthopedic journey.
• mymobility Digital Care Management Platform Digital care management platform enabling surgeons to send patient education and track recovery through connected health technology, compatible with smart implants like Persona IQ.
• OptiVu Mixed Reality Navigation Platform Mixed reality surgical planning and guidance platform providing enhanced visualization during orthopedic procedures.
• OrthoGrid Hip AI Platform AI-powered fluoroscopy-based surgical assistance platform for total hip replacement providing real-time guidance to enhance intraoperative efficiency and surgical accuracy. Acquired from OrthoGrid Systems in 2024.
• THINK Surgical TMINI Miniature Robotic System Miniature robotic system for total knee replacement procedures, distributed exclusively by Zimmer Biomet through partnership with THINK Surgical. Covers approximately 70% of the U.S. market by implant volume.
• mBôs Autonomous Robotic System CT-based semi-autonomous AI-navigated robotic system for total knee arthroplasty, acquired from Monogram Technologies for approximately $177 million. Clinical studies underway.
• Paragon 28 Phantom Curved TTC Nail First anatomy-driven curved foot implant designed to match patients' natural hindfoot anatomy. Commercially launched February 2026 by Paragon 28, which Zimmer Biomet acquired for $1.2 billion in April 2025.
• Persona OsseoTi Keel Tibia Tibial knee implant component with OsseoTi porous metal technology for enhanced bone integration and fixation.
• Persona Revision Knee System Comprehensive revision knee system designed for complex revision procedures with multiple implant options and instrumentation.
• Z1 Triple-Taper Hip System Cemented and cementless femoral hip stem system with triple-taper design for primary hip replacement.
• iTaperloc Complete and iG7 Hip System (Iodine-treated hip implants) Iodine-treated hip implants (iTaperloc Complete and iG7 Hip System) that reduce periprosthetic joint infection risk. Japanese Ministry of Health approval received September 2025; FDA Breakthrough Device Designation October 2025.
• Bone Cement Products (Tekcem 1G/3G Antibiotic Bone Cements) Bone cement products including antibiotic-loaded cement for joint replacement fixation. Tekcem 1G and 3G antibiotic bone cements launched in India.
• WalkAI Recovery Tracking Platform AI-powered knee replacement recovery tracking platform monitoring patient progress post-surgery, deployed across 180+ surgeons for 20,000+ patients in Australia and New Zealand.
• ZBX ASC Solutions Specialized solutions package for ambulatory surgery centers, providing products and services tailored to outpatient orthopedic procedures.
• C3 VBC Solutions (Value-Based Care) Zimmer Biomet's value-based care offering for healthcare providers participating in Comprehensive Care for Joint Replacement and similar bundled payment programs.
• OSSIS 3D-Printed Personalized Implants Personalized 3D-printed implants for complex hip and pelvic replacements, acquired via the OSSIS acquisition (May 2023).
• Embody Collagen-Based Biointegrative Products Collagen-based biointegrative products for soft tissue healing in sports medicine, acquired via the Embody, Inc. acquisition (January 2023).

Quantifiable outcome

• Q1 2026 revenue of $2.09 billion, up 9.3% year-over-year
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature10 records

Partnerships

Two partnerships are on record, tiered core.

• OrthoGrid SystemscoreStrategic or Co-development Partner · 7 August 2024Zimmer Biomet signed definitive agreement to acquire OrthoGrid Systems, including Hip AI platform for AI-driven surgical guidance in total hip replacement. The acquisition includes FDA-cleared applications and patents. Expected to close by end of Q4 2024, expanding Zimmer Biomet's AI-powered surgical guidance portfolio.
• THINK SurgicalcoreChannel Partner/ Reseller/ Distributor · 1 January 2024Exclusive distribution partnership for TMINI Miniature Robotic System. The partnership has driven significant volume growth, with TMINI reaching 5,000th procedure milestone in May 2026, representing fivefold increase over 12 months. Expanded implant compatibility now covers approximately 70% of U.S. market by implant volume.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• NuVasive (Globus Medical): NuVasive, now part of Globus Medical, is a direct competitor in spine surgery and enabling technologies, overlapping with Zimmer Biomet's spine implant and surgical assistance offerings.
• Smith+Nephew: Smith+Nephew is a global medical device company with directly overlapping joint reconstruction, sports medicine, and trauma franchises, and the CORI robotic surgical system competing with ROSA/TMINI. Same end customers (orthopedic surgeons and hospitals) and comparable GTM model.
• THINK Surgical: THINK Surgical partners with Zimmer Biomet for U.S. distribution of TMINI while also developing its own TPLAN surgical workstation and ID-CUT/TSolutionOne robots, making it both a partner and adjacent competitor in robotic-assisted knee surgery.
• Stryker Corporation: Stryker is Zimmer Biomet's largest direct competitor across joint reconstruction, trauma, and surgical robotics (Mako system). Both companies serve orthopedic surgeons and hospitals with implants and robotic-assisted surgery platforms globally.
• Globus Medical: Globus Medical (post-NuVasive merger) competes with Zimmer Biomet in spine and musculoskeletal disorders, with an expanding orthopedic robotics and enabling technology portfolio (ExcelsiusGPS). Strong overlap in spine implants and motion preservation.

Broad incumbents

• Integra LifeSciences: Integra LifeSciences competes in orthopedic extremities, neurosurgery, and tissue technologies with a portfolio that overlaps with Zimmer Biomet's trauma, extremities, and regenerative medicine segments.
• Medtronic (Spine & Biologics): Medtronic competes with Zimmer Biomet in spine and biologics through its Cranial & Spinal Technologies business, while also operating broadly across cardiology, diabetes, and other medtech verticals. Highly relevant for spine overlap.
• Johnson & Johnson (DePuy Synthes / MedTech): Johnson & Johnson's MedTech division (including DePuy Synthes) competes directly with Zimmer Biomet in orthopedics, spine, and trauma as part of a much broader medical device portfolio. DePuy Synthes is one of the 'Big Three' orthopedic incumbents alongside Stryker and Zimmer Biomet.

Others

• Canary Medical: Canary Medical licenses its canturio te sensor technology into Zimmer Biomet's Persona IQ smart knee implant. Not a direct competitor but a strategic enabling technology partner for Zimmer Biomet's connected implant strategy.

Emerging players

• ConforMIS: ConforMIS specializes in patient-specific, 3D-printed knee and hip implants, directly competing with Zimmer Biomet's Persona and OSSIS patient-matched implant franchises. Smaller scale, but focused differentiation in personalized joint replacement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zimmerbiomet
• Xx.com/zimmerbiomet
• Facebookfacebook.com/ZimmerBiomet-1780224515629844

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries6 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A34 records

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zimmer Biomet